The PubMed listing documents a multicentre cohort study titled “Cumulative Metformin Use and Hepatocellular Carcinoma Risk After HCV SVR.” The citation indicates publication in Liver International (Aug 2026), volume 46, issue 8, article e70798. The work is presented as a multicentre cohort investigation examining the association between cumulative metformin use and risk of hepatocellular carcinoma (HCC) among patients who have achieved HCV sustained virological response (SVR).
The PubMed entry provides bibliographic metadata (journal, volume, DOI, PMID, PMCID) and lists author names and institutional affiliations but, in the content provided here, does not include the study abstract or numeric results.
The article is authored by Henar Calvo-Sánchez et al. and lists multiple coauthors. Affiliated institutions include the Service of Gastroenterology at University Hospital of Guadalajara, the Translational Research Group on Cellular Immunology (GITIC) at Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), the Department of Medicine and Medical Specialties at the University of Alcalá, the Service of Gastroenterology at University Hospital Fundación Alcorcón, and several other university and hospital departments across Spain. The authorship and affiliations indicate a multicentre Spanish research collaboration.
The article title specifies a multicentre cohort study assessing the relationship between cumulative exposure to metformin and subsequent HCC risk after patients achieve HCV SVR. The title implies a longitudinal observational design in which metformin exposure was quantified cumulatively and HCC risk was measured after viral clearance, but the PubMed-record excerpt shown does not provide the study period, cohort size, inclusion or exclusion criteria, or how exposures and outcomes were defined and ascertained.
The PubMed record provides the following identifiers and access points:
The entry also includes a Wiley DOI link and a PubMed Central full-text link, which can be used to access the complete article for full methodological and result details.
From the PubMed page content available here, the record documents:
The presence of the PMCID suggests the full article is accessible in PubMed Central, which is the recommended source for the complete report including abstract, methods, results, tables and figures.
The excerpt of the PubMed page provided does not include key scientific details that clinicians and researchers commonly need to appraise and apply findings. Specifically, the following were not reported in this PubMed snippet and should be obtained from the full text:
Because the PubMed page excerpt shown here lacks the abstract and results, these items are not available from the source provided and must be retrieved from the full article.
The PubMed entry provides a PMCID indicating the full article is available in PubMed Central. Use the PMCID link or the DOI (10.1111/liv.70798) to retrieve the full text, which will contain the abstract, detailed methods, numerical results, tables, figures and authors’ interpretation.
For clinicians seeking to interpret the implications for practice (for example, whether metformin use is associated with reduced or increased HCC risk after achieving HCV SVR), consult the complete article and evaluate the following once available:
If the full text is unavailable or further clarification is needed, contact the corresponding author or review related commentary and guideline updates addressing pharmacologic prevention strategies for HCC after HCV cure.
The PubMed entry documents a multicentre cohort study on cumulative metformin use and HCC risk after HCV SVR with full bibliographic details and author affiliations. However, the abstract, methods, numerical results and authors’ conclusions are not present in the source text provided here. Clinicians and researchers should access the full-text article via the PMCID or DOI to obtain the detailed data necessary for critical appraisal and clinical interpretation.